Theravance Biopharma (TBPH) Stock Chart & Stock Price History $14.58 +0.17 (+1.18%) Closing price 04:00 PM EasternExtended Trading$14.60 +0.03 (+0.17%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Theravance Biopharma Stock Price Performance The Theravance Biopharma (TBPH) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 80.00%, with a year-to-date return of 54.94%. In the past month, the stock has increased 4.52%, reflecting recent market activity. As of the latest close, Theravance Biopharma traded at $14.41 with a market cap of $725.69 million and volume of 276,419 shares. Five years ago, the stock traded at $14.90, representing a 2.15% decrease over that period. At the time, it had a market cap of $952.94 million and a volume of 181,155 shares. Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+1.11%1 Month Performance+4.52%3 Month Performance+30.35%Year-To-Date Performance+54.94%1 Year Performance+80.00%5 Year Performance-2.15% TBPH Stock Chart for Monday, October, 6, 2025 TBPH Chart by TradingView Theravance Biopharma Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/06/2025$14.41$14.58+1.18%$15.15$14.48522,520 shs$734.25 million10/03/2025$14.07$14.41+2.42%$14.44$14.08276,419 shs$725.69 million10/02/2025$14.42$14.07-2.43%$14.52$14.00315,209 shs$708.57 million10/01/2025$14.60$14.42-1.23%$14.81$14.30315,409 shs$726.19 million09/30/2025$14.43$14.60+1.18%$14.87$14.07447,799 shs$735.26 million09/29/2025$14.07$14.43+2.56%$14.55$13.97318,754 shs$726.70 million09/26/2025$13.79$14.07+2.03%$14.14$13.66309,109 shs$708.57 million09/25/2025$14.05$13.79-1.85%$14.04$13.73225,764 shs$694.46 million09/24/2025$14.07$14.05-0.14%$14.39$13.86228,532 shs$707.57 million09/23/2025$14.07$14.07$14.12$13.94246,620 shs$708.57 million Get the Latest News and Ratings for TBPH and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. 09/22/2025$13.88$14.07+1.37%$14.25$13.65377,753 shs$708.57 million09/19/2025$14.47$13.88-4.08%$14.54$13.80465,356 shs$699.00 million09/18/2025$14.05$14.47+2.99%$14.50$13.99442,496 shs$728.72 million09/17/2025$13.87$14.05+1.30%$14.15$13.91304,729 shs$707.56 million09/16/2025$14.40$13.87-3.68%$14.35$13.86450,603 shs$698.49 million09/15/2025$14.30$14.40+0.70%$14.40$13.88447,517 shs$725.20 million09/12/2025$13.70$14.30+4.38%$14.42$13.87848,891 shs$720.16 million09/11/2025$13.64$13.70+0.44%$13.77$13.47360,355 shs$689.93 million09/10/2025$13.76$13.64-0.87%$13.94$13.54367,401 shs$686.91 million09/09/2025$13.92$13.76-1.15%$13.97$13.58340,446 shs$692.97 million09/08/2025$13.95$13.92-0.22%$14.21$13.81387,504 shs$701.01 million09/05/2025$14.05$13.95-0.71%$14.36$13.91659,988 shs$702.52 million Related Companies IMVT Stock Price Chart APLS Stock Price Chart RARE Stock Price Chart HCM Stock Price Chart KNSA Stock Price Chart OGN Stock Price Chart MLYS Stock Price Chart ALVO Stock Price Chart IBRX Stock Price Chart BHC Stock Price Chart Receive TBPH Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Theravance Biopharma and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:TBPH) was last updated on 10/6/2025 by MarketBeat.com Staff From Our PartnersMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredIs This Warren’s Buffett’s #1 AI Investment?Did you know that Warren Buffett is investing in what Jeff Brown believes will be the next generation of artif...Brownstone Research | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredThe Fed Just Got Kneecapped — Here’s What Happens NextDonald Trump has done it again! This time, with the signing of the highly controversial new law S.1582 — he...Banyan Hill Publishing | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Theravance Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Theravance Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
